Anti‐inflammatory Action of Angiotensin‐(1–7) and the Angiotensin Type 2 Receptor Agonist Compound 21 in Hypothalamic Microglia

Meng Liu,Peng Shi,Ulrike Muscha Steckelings,Colin Sumners
DOI: https://doi.org/10.1096/fasebj.27.1_supplement.692.3
2013-01-01
Abstract:Recent studies indicate that the hypertensive action of angiotensin II (Ang II) mediated by its type 1 receptors in central cardiovascular control centers includes induction of the resident neuroimmune system, in particular microglia, in the paraventricular nucleus of the hypothalamus (PVN). Our objective here was to investigate the potential counteractive effects of the protective arms of the renin angiotensin system, angiotensin‐(1–7)/Mas and angiotensin type 2 receptors (AT2R), on activation of hypothalamic microglia. Real time PCR analyses revealed the presence of similar levels of Mas and AT2R in the PVN, as well as other cardiovascular control centers, of normotensive (SD; Sprague Dawley) and spontaneously hypertensive rats (SHR). Both Mas and AT2R were maintained in microglia prepared from the hypothalamus these rat strains, according to respective PCR and receptor binding analyses. Treatment of SD or SHR cultures with either Ang‐(1–7) (100–1000nM) or the AT2R agonist Compound 21 (C21; 100–1000nM) for 24 h elicited significant (~30%) decreases in basal levels of mRNAs for CD11b (marker of microglial activation) and the pro‐inflammatory cytokine interleukin‐1β. These data support the idea that both Mas and AT2R have an anti‐inflammatory role, and potentially an antihypertensive role, in the hypothalamus. Supported by HL‐076803
What problem does this paper attempt to address?